Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-007375

Chief Financial Officer gave up 1,308 shares (to pay taxes)

  • Chief Financial Officer acquired 3,875 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ruffo Frank Chief Financial Officer 2021-02-01 Option exercise +3,875 216,497 D
Ruffo Frank Chief Financial Officer 2021-02-01 Shares withheld for taxes −1,308 $21.35 $27,926 215,189 D
Derivatives
Ruffo Frank Chief Financial Officer 2021-02-01 Option exercise · Restricted Stock Units −3,875 3,875 D
Loading xslF345X03/doc4.xml…